140 related articles for article (PubMed ID: 12215297)
1. Expression of telomerase genes in cancer development in atypical hyperplasia of the mammary duct.
Song M; Mi X; Li B; Zhu J; Gao Y; Cui S; Song J
Chin Med J (Engl); 2002 Aug; 115(8):1221-5. PubMed ID: 12215297
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between expressions of telomerase genes and apoptosis related genes in mammary ductal atypical hyperplasia].
Song M; Li BL; Mi XY; Gao YX; Song JY
Ai Zheng; 2002 May; 21(5):484-8. PubMed ID: 12452037
[TBL] [Abstract][Full Text] [Related]
3. [Expression of telomerase genes in mamary atypical ductal hyperplasia].
Song M; Mi X; Li B; Zhu J; Gao Y; Cui S; Song J
Zhonghua Bing Li Xue Za Zhi; 2002 Feb; 31(1):30-3. PubMed ID: 11955332
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
[TBL] [Abstract][Full Text] [Related]
5. [Telomerase hTRT mRNA expression in oral squamous cell carcinogenesis].
Zhang L; Zhang W; Liu Z
Hua Xi Kou Qiang Yi Xue Za Zhi; 1999 Nov; 17(4):307-9. PubMed ID: 12539372
[TBL] [Abstract][Full Text] [Related]
6. Telomerase hTR and hTRT gene expression in oral precancerous lesions and squamous cell carcinomas.
Zhang L; Zhang W
Chin J Dent Res; 1999 May; 2(2):43-8. PubMed ID: 10863406
[TBL] [Abstract][Full Text] [Related]
7. [Relationship among telomerase activity, telomerase RNA and telomerase catalytic subunit gene expression and their significance in non small-cell lung cancer].
Wang J; Liu X; Jiang W
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):289-92. PubMed ID: 11783109
[TBL] [Abstract][Full Text] [Related]
8. [Expression of telomerase reverse transcriptase in premalignant esophageal squamous dysplasia].
Yu HP; Xu SQ; Liu L; Shi LY; Lu WH
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Oct; 24(10):920-3. PubMed ID: 14575609
[TBL] [Abstract][Full Text] [Related]
9. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
[TBL] [Abstract][Full Text] [Related]
10. Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.
Yashima K; Milchgrub S; Gollahon LS; Maitra A; Saboorian MH; Shay JW; Gazdar AF
Clin Cancer Res; 1998 Jan; 4(1):229-34. PubMed ID: 9516976
[TBL] [Abstract][Full Text] [Related]
11. [Cleavage of telomerase RNA component by two DNAzymes and their effects on expression of two apoptosis-related genes in human mammary cancer cells].
Zhao JM; Li MY; Yang Z; Li Z; Zhang Y
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):638-42. PubMed ID: 15958297
[TBL] [Abstract][Full Text] [Related]
12. [The study on the correlation between telomerase and histopathologic features of retinoblastoma].
Ren RJ; Li B; Sun XL; Zheng BH; Li LQ; Chen CX
Zhonghua Yan Ke Za Zhi; 2004 Apr; 40(4):234-8. PubMed ID: 15268829
[TBL] [Abstract][Full Text] [Related]
13. [Expression of telomerase genes in human tumors].
Yuan X; Zhang B; Ying J; Jin Y; Hou L
Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):16-9. PubMed ID: 11866885
[TBL] [Abstract][Full Text] [Related]
14. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
15. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ.
Liu J; Baykal A; Fung KM; Thompson-Lanza JA; Hoque A; Lippman SM; Sahin A
Int J Oncol; 2004 Apr; 24(4):879-84. PubMed ID: 15010825
[TBL] [Abstract][Full Text] [Related]
16. Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer.
Dhar S; Bhargava R; Yunes M; Li B; Goyal J; Naber SP; Wazer DE; Band V
Clin Cancer Res; 2001 Nov; 7(11):3393-8. PubMed ID: 11705853
[TBL] [Abstract][Full Text] [Related]
17. Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities.
Wang TT; Frezza EE; Ma R; Hu SY; Liu CZ; Zhang GY; Wachtel MS; Lü XM; Feng JB; Lü CX
Chin Med J (Engl); 2008 Oct; 121(20):1969-74. PubMed ID: 19080258
[TBL] [Abstract][Full Text] [Related]
18. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.
Novakovic S; Hocevar M; Zgajnar J; Besic N; Stegel V
Oncol Rep; 2004 Jan; 11(1):245-52. PubMed ID: 14654933
[TBL] [Abstract][Full Text] [Related]
19. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
